nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—stomach cancer—Barrett's esophagus	0.49	1	CtDrD
Doxorubicin—ABCC3—Omeprazole—Barrett's esophagus	0.11	0.357	CbGbCtD
Doxorubicin—CYP1B1—Omeprazole—Barrett's esophagus	0.0949	0.308	CbGbCtD
Doxorubicin—ABCG2—Omeprazole—Barrett's esophagus	0.0451	0.147	CbGbCtD
Doxorubicin—CYP3A4—Esomeprazole—Barrett's esophagus	0.0165	0.0537	CbGbCtD
Doxorubicin—ABCB1—Omeprazole—Barrett's esophagus	0.0163	0.0528	CbGbCtD
Doxorubicin—CYP2D6—Omeprazole—Barrett's esophagus	0.0153	0.0498	CbGbCtD
Doxorubicin—CYP3A4—Omeprazole—Barrett's esophagus	0.00975	0.0317	CbGbCtD
Doxorubicin—ABCB11—bile—Barrett's esophagus	0.00747	0.183	CbGeAlD
Doxorubicin—ABCC2—bile—Barrett's esophagus	0.0038	0.0932	CbGeAlD
Doxorubicin—AKR1A1—smooth muscle tissue—Barrett's esophagus	0.00167	0.041	CbGeAlD
Doxorubicin—AKR1A1—digestive system—Barrett's esophagus	0.00132	0.0324	CbGeAlD
Doxorubicin—NOS1—epithelium—Barrett's esophagus	0.00132	0.0323	CbGeAlD
Doxorubicin—NOS1—smooth muscle tissue—Barrett's esophagus	0.00127	0.0311	CbGeAlD
Doxorubicin—NDUFS2—smooth muscle tissue—Barrett's esophagus	0.00126	0.0309	CbGeAlD
Doxorubicin—NDUFS3—smooth muscle tissue—Barrett's esophagus	0.00124	0.0305	CbGeAlD
Doxorubicin—NDUFS7—digestive system—Barrett's esophagus	0.0012	0.0295	CbGeAlD
Doxorubicin—AURKA—digestive system—Barrett's esophagus	0.00112	0.0274	CbGeAlD
Doxorubicin—YWHAG—smooth muscle tissue—Barrett's esophagus	0.00109	0.0266	CbGeAlD
Doxorubicin—NOS1—digestive system—Barrett's esophagus	0.001	0.0246	CbGeAlD
Doxorubicin—NOS3—epithelium—Barrett's esophagus	0.001	0.0245	CbGeAlD
Doxorubicin—NDUFS2—digestive system—Barrett's esophagus	0.000995	0.0244	CbGeAlD
Doxorubicin—NDUFS3—digestive system—Barrett's esophagus	0.000983	0.0241	CbGeAlD
Doxorubicin—RALBP1—smooth muscle tissue—Barrett's esophagus	0.00098	0.024	CbGeAlD
Doxorubicin—NOS3—smooth muscle tissue—Barrett's esophagus	0.000964	0.0236	CbGeAlD
Doxorubicin—DHCR7—digestive system—Barrett's esophagus	0.000934	0.0229	CbGeAlD
Doxorubicin—AKR1C3—smooth muscle tissue—Barrett's esophagus	0.000904	0.0222	CbGeAlD
Doxorubicin—YWHAG—digestive system—Barrett's esophagus	0.000857	0.021	CbGeAlD
Doxorubicin—XDH—digestive system—Barrett's esophagus	0.000836	0.0205	CbGeAlD
Doxorubicin—ABCB11—digestive system—Barrett's esophagus	0.000816	0.02	CbGeAlD
Doxorubicin—RALBP1—digestive system—Barrett's esophagus	0.000774	0.019	CbGeAlD
Doxorubicin—NOS3—digestive system—Barrett's esophagus	0.000761	0.0187	CbGeAlD
Doxorubicin—NQO1—epithelium—Barrett's esophagus	0.000761	0.0187	CbGeAlD
Doxorubicin—NQO1—smooth muscle tissue—Barrett's esophagus	0.000733	0.018	CbGeAlD
Doxorubicin—CBR1—digestive system—Barrett's esophagus	0.000722	0.0177	CbGeAlD
Doxorubicin—NQO1—digestive system—Barrett's esophagus	0.000579	0.0142	CbGeAlD
Doxorubicin—ABCC3—digestive system—Barrett's esophagus	0.00052	0.0127	CbGeAlD
Doxorubicin—ABCC10—digestive system—Barrett's esophagus	0.000517	0.0127	CbGeAlD
Doxorubicin—CYP1B1—smooth muscle tissue—Barrett's esophagus	0.000515	0.0126	CbGeAlD
Doxorubicin—ABCC2—digestive system—Barrett's esophagus	0.000415	0.0102	CbGeAlD
Doxorubicin—CYP1B1—digestive system—Barrett's esophagus	0.000407	0.00997	CbGeAlD
Doxorubicin—Purpura—Omeprazole—Barrett's esophagus	0.000296	0.00261	CcSEcCtD
Doxorubicin—Purpura—Esomeprazole—Barrett's esophagus	0.000296	0.00261	CcSEcCtD
Doxorubicin—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.000293	0.00258	CcSEcCtD
Doxorubicin—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.000293	0.00258	CcSEcCtD
Doxorubicin—Hyponatraemia—Omeprazole—Barrett's esophagus	0.000287	0.00252	CcSEcCtD
Doxorubicin—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.000287	0.00252	CcSEcCtD
Doxorubicin—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Pain in extremity—Esomeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Diplopia—Omeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Diplopia—Esomeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Pain in extremity—Omeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000286	0.00251	CcSEcCtD
Doxorubicin—Migraine—Esomeprazole—Barrett's esophagus	0.000281	0.00247	CcSEcCtD
Doxorubicin—Migraine—Omeprazole—Barrett's esophagus	0.000281	0.00247	CcSEcCtD
Doxorubicin—CYP2B6—digestive system—Barrett's esophagus	0.000279	0.00685	CbGeAlD
Doxorubicin—Face oedema—Omeprazole—Barrett's esophagus	0.000276	0.00243	CcSEcCtD
Doxorubicin—Face oedema—Esomeprazole—Barrett's esophagus	0.000276	0.00243	CcSEcCtD
Doxorubicin—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000268	0.00236	CcSEcCtD
Doxorubicin—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000268	0.00236	CcSEcCtD
Doxorubicin—Dry skin—Omeprazole—Barrett's esophagus	0.000262	0.0023	CcSEcCtD
Doxorubicin—Dry skin—Esomeprazole—Barrett's esophagus	0.000262	0.0023	CcSEcCtD
Doxorubicin—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000261	0.0023	CcSEcCtD
Doxorubicin—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000261	0.0023	CcSEcCtD
Doxorubicin—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00026	0.00229	CcSEcCtD
Doxorubicin—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00026	0.00229	CcSEcCtD
Doxorubicin—Breast disorder—Omeprazole—Barrett's esophagus	0.000258	0.00227	CcSEcCtD
Doxorubicin—Breast disorder—Esomeprazole—Barrett's esophagus	0.000258	0.00227	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000257	0.00226	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000257	0.00226	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000257	0.00226	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000257	0.00226	CcSEcCtD
Doxorubicin—Gastritis—Esomeprazole—Barrett's esophagus	0.000253	0.00222	CcSEcCtD
Doxorubicin—Gastritis—Omeprazole—Barrett's esophagus	0.000253	0.00222	CcSEcCtD
Doxorubicin—Muscular weakness—Omeprazole—Barrett's esophagus	0.000252	0.00222	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000252	0.00222	CcSEcCtD
Doxorubicin—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000252	0.00222	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000252	0.00222	CcSEcCtD
Doxorubicin—Abdominal distension—Omeprazole—Barrett's esophagus	0.000248	0.00219	CcSEcCtD
Doxorubicin—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000248	0.00219	CcSEcCtD
Doxorubicin—Influenza—Omeprazole—Barrett's esophagus	0.000247	0.00217	CcSEcCtD
Doxorubicin—Dysphagia—Esomeprazole—Barrett's esophagus	0.000247	0.00217	CcSEcCtD
Doxorubicin—Dysphagia—Omeprazole—Barrett's esophagus	0.000247	0.00217	CcSEcCtD
Doxorubicin—Asthma—Omeprazole—Barrett's esophagus	0.000247	0.00217	CcSEcCtD
Doxorubicin—Asthma—Esomeprazole—Barrett's esophagus	0.000247	0.00217	CcSEcCtD
Doxorubicin—Influenza—Esomeprazole—Barrett's esophagus	0.000247	0.00217	CcSEcCtD
Doxorubicin—Pancreatitis—Omeprazole—Barrett's esophagus	0.000242	0.00213	CcSEcCtD
Doxorubicin—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000242	0.00213	CcSEcCtD
Doxorubicin—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00024	0.00212	CcSEcCtD
Doxorubicin—Angina pectoris—Omeprazole—Barrett's esophagus	0.00024	0.00212	CcSEcCtD
Doxorubicin—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000234	0.00206	CcSEcCtD
Doxorubicin—Pancytopenia—Omeprazole—Barrett's esophagus	0.000234	0.00206	CcSEcCtD
Doxorubicin—Neutropenia—Omeprazole—Barrett's esophagus	0.000231	0.00203	CcSEcCtD
Doxorubicin—Dysuria—Esomeprazole—Barrett's esophagus	0.000231	0.00203	CcSEcCtD
Doxorubicin—Dysuria—Omeprazole—Barrett's esophagus	0.000231	0.00203	CcSEcCtD
Doxorubicin—Neutropenia—Esomeprazole—Barrett's esophagus	0.000231	0.00203	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000229	0.00202	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000229	0.00202	CcSEcCtD
Doxorubicin—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000228	0.00201	CcSEcCtD
Doxorubicin—Pollakiuria—Omeprazole—Barrett's esophagus	0.000228	0.00201	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000225	0.00198	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000225	0.00198	CcSEcCtD
Doxorubicin—Weight increased—Omeprazole—Barrett's esophagus	0.000225	0.00198	CcSEcCtD
Doxorubicin—Weight increased—Esomeprazole—Barrett's esophagus	0.000225	0.00198	CcSEcCtD
Doxorubicin—Weight decreased—Esomeprazole—Barrett's esophagus	0.000223	0.00197	CcSEcCtD
Doxorubicin—Weight decreased—Omeprazole—Barrett's esophagus	0.000223	0.00197	CcSEcCtD
Doxorubicin—Infestation—Omeprazole—Barrett's esophagus	0.00022	0.00194	CcSEcCtD
Doxorubicin—Infestation NOS—Omeprazole—Barrett's esophagus	0.00022	0.00194	CcSEcCtD
Doxorubicin—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00022	0.00194	CcSEcCtD
Doxorubicin—Infestation—Esomeprazole—Barrett's esophagus	0.00022	0.00194	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000218	0.00192	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000218	0.00192	CcSEcCtD
Doxorubicin—Renal failure—Omeprazole—Barrett's esophagus	0.000216	0.0019	CcSEcCtD
Doxorubicin—Renal failure—Esomeprazole—Barrett's esophagus	0.000216	0.0019	CcSEcCtD
Doxorubicin—Jaundice—Omeprazole—Barrett's esophagus	0.000214	0.00189	CcSEcCtD
Doxorubicin—Stomatitis—Esomeprazole—Barrett's esophagus	0.000214	0.00189	CcSEcCtD
Doxorubicin—Stomatitis—Omeprazole—Barrett's esophagus	0.000214	0.00189	CcSEcCtD
Doxorubicin—Jaundice—Esomeprazole—Barrett's esophagus	0.000214	0.00189	CcSEcCtD
Doxorubicin—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000214	0.00188	CcSEcCtD
Doxorubicin—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000214	0.00188	CcSEcCtD
Doxorubicin—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000214	0.00188	CcSEcCtD
Doxorubicin—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000214	0.00188	CcSEcCtD
Doxorubicin—CYP3A4—digestive system—Barrett's esophagus	0.000211	0.00517	CbGeAlD
Doxorubicin—Haematuria—Omeprazole—Barrett's esophagus	0.00021	0.00185	CcSEcCtD
Doxorubicin—Haematuria—Esomeprazole—Barrett's esophagus	0.00021	0.00185	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000208	0.00183	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000208	0.00183	CcSEcCtD
Doxorubicin—Epistaxis—Esomeprazole—Barrett's esophagus	0.000208	0.00183	CcSEcCtD
Doxorubicin—Epistaxis—Omeprazole—Barrett's esophagus	0.000208	0.00183	CcSEcCtD
Doxorubicin—CYP2D6—digestive system—Barrett's esophagus	0.000208	0.00509	CbGeAlD
Doxorubicin—Sinusitis—Esomeprazole—Barrett's esophagus	0.000206	0.00182	CcSEcCtD
Doxorubicin—Sinusitis—Omeprazole—Barrett's esophagus	0.000206	0.00182	CcSEcCtD
Doxorubicin—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000205	0.00181	CcSEcCtD
Doxorubicin—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000205	0.00181	CcSEcCtD
Doxorubicin—Bradycardia—Omeprazole—Barrett's esophagus	0.000201	0.00177	CcSEcCtD
Doxorubicin—Bradycardia—Esomeprazole—Barrett's esophagus	0.000201	0.00177	CcSEcCtD
Doxorubicin—Rhinitis—Omeprazole—Barrett's esophagus	0.000198	0.00174	CcSEcCtD
Doxorubicin—Rhinitis—Esomeprazole—Barrett's esophagus	0.000198	0.00174	CcSEcCtD
Doxorubicin—Hepatitis—Omeprazole—Barrett's esophagus	0.000198	0.00174	CcSEcCtD
Doxorubicin—Hepatitis—Esomeprazole—Barrett's esophagus	0.000198	0.00174	CcSEcCtD
Doxorubicin—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000197	0.00173	CcSEcCtD
Doxorubicin—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000197	0.00173	CcSEcCtD
Doxorubicin—ABCB1—epithelium—Barrett's esophagus	0.000196	0.00481	CbGeAlD
Doxorubicin—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000196	0.00173	CcSEcCtD
Doxorubicin—Pharyngitis—Omeprazole—Barrett's esophagus	0.000196	0.00173	CcSEcCtD
Doxorubicin—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000195	0.00172	CcSEcCtD
Doxorubicin—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000195	0.00172	CcSEcCtD
Doxorubicin—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000195	0.00171	CcSEcCtD
Doxorubicin—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000195	0.00171	CcSEcCtD
Doxorubicin—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000194	0.00171	CcSEcCtD
Doxorubicin—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000194	0.00171	CcSEcCtD
Doxorubicin—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000194	0.0017	CcSEcCtD
Doxorubicin—Urethral disorder—Omeprazole—Barrett's esophagus	0.000194	0.0017	CcSEcCtD
Doxorubicin—Visual impairment—Omeprazole—Barrett's esophagus	0.00019	0.00168	CcSEcCtD
Doxorubicin—Visual impairment—Esomeprazole—Barrett's esophagus	0.00019	0.00168	CcSEcCtD
Doxorubicin—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000187	0.00164	CcSEcCtD
Doxorubicin—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000187	0.00164	CcSEcCtD
Doxorubicin—Eye disorder—Esomeprazole—Barrett's esophagus	0.000185	0.00163	CcSEcCtD
Doxorubicin—Eye disorder—Omeprazole—Barrett's esophagus	0.000185	0.00163	CcSEcCtD
Doxorubicin—Tinnitus—Esomeprazole—Barrett's esophagus	0.000184	0.00162	CcSEcCtD
Doxorubicin—Tinnitus—Omeprazole—Barrett's esophagus	0.000184	0.00162	CcSEcCtD
Doxorubicin—Flushing—Esomeprazole—Barrett's esophagus	0.000183	0.00161	CcSEcCtD
Doxorubicin—Flushing—Omeprazole—Barrett's esophagus	0.000183	0.00161	CcSEcCtD
Doxorubicin—Immune system disorder—Omeprazole—Barrett's esophagus	0.000178	0.00157	CcSEcCtD
Doxorubicin—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000178	0.00157	CcSEcCtD
Doxorubicin—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000178	0.00157	CcSEcCtD
Doxorubicin—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000178	0.00157	CcSEcCtD
Doxorubicin—Chills—Omeprazole—Barrett's esophagus	0.000177	0.00156	CcSEcCtD
Doxorubicin—Chills—Esomeprazole—Barrett's esophagus	0.000177	0.00156	CcSEcCtD
Doxorubicin—Alopecia—Esomeprazole—Barrett's esophagus	0.000175	0.00154	CcSEcCtD
Doxorubicin—Alopecia—Omeprazole—Barrett's esophagus	0.000175	0.00154	CcSEcCtD
Doxorubicin—Mental disorder—Esomeprazole—Barrett's esophagus	0.000173	0.00152	CcSEcCtD
Doxorubicin—Mental disorder—Omeprazole—Barrett's esophagus	0.000173	0.00152	CcSEcCtD
Doxorubicin—Malnutrition—Omeprazole—Barrett's esophagus	0.000172	0.00151	CcSEcCtD
Doxorubicin—Malnutrition—Esomeprazole—Barrett's esophagus	0.000172	0.00151	CcSEcCtD
Doxorubicin—Flatulence—Omeprazole—Barrett's esophagus	0.000169	0.00149	CcSEcCtD
Doxorubicin—Flatulence—Esomeprazole—Barrett's esophagus	0.000169	0.00149	CcSEcCtD
Doxorubicin—Tension—Esomeprazole—Barrett's esophagus	0.000169	0.00149	CcSEcCtD
Doxorubicin—Tension—Omeprazole—Barrett's esophagus	0.000169	0.00149	CcSEcCtD
Doxorubicin—Dysgeusia—Omeprazole—Barrett's esophagus	0.000168	0.00148	CcSEcCtD
Doxorubicin—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000168	0.00148	CcSEcCtD
Doxorubicin—Nervousness—Esomeprazole—Barrett's esophagus	0.000167	0.00147	CcSEcCtD
Doxorubicin—Nervousness—Omeprazole—Barrett's esophagus	0.000167	0.00147	CcSEcCtD
Doxorubicin—Back pain—Omeprazole—Barrett's esophagus	0.000166	0.00146	CcSEcCtD
Doxorubicin—Back pain—Esomeprazole—Barrett's esophagus	0.000166	0.00146	CcSEcCtD
Doxorubicin—Muscle spasms—Omeprazole—Barrett's esophagus	0.000165	0.00146	CcSEcCtD
Doxorubicin—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000165	0.00146	CcSEcCtD
Doxorubicin—Vision blurred—Esomeprazole—Barrett's esophagus	0.000162	0.00143	CcSEcCtD
Doxorubicin—Vision blurred—Omeprazole—Barrett's esophagus	0.000162	0.00143	CcSEcCtD
Doxorubicin—NOS2—IL12-mediated signaling events—RELA—Barrett's esophagus	0.000162	0.0034	CbGpPWpGaD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.000161	0.00338	CbGpPWpGaD
Doxorubicin—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00016	0.0014	CcSEcCtD
Doxorubicin—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00016	0.0014	CcSEcCtD
Doxorubicin—Anaemia—Esomeprazole—Barrett's esophagus	0.000159	0.0014	CcSEcCtD
Doxorubicin—Anaemia—Omeprazole—Barrett's esophagus	0.000159	0.0014	CcSEcCtD
Doxorubicin—Agitation—Esomeprazole—Barrett's esophagus	0.000158	0.00139	CcSEcCtD
Doxorubicin—Agitation—Omeprazole—Barrett's esophagus	0.000158	0.00139	CcSEcCtD
Doxorubicin—Malaise—Omeprazole—Barrett's esophagus	0.000155	0.00137	CcSEcCtD
Doxorubicin—Malaise—Esomeprazole—Barrett's esophagus	0.000155	0.00137	CcSEcCtD
Doxorubicin—Vertigo—Omeprazole—Barrett's esophagus	0.000155	0.00136	CcSEcCtD
Doxorubicin—Vertigo—Esomeprazole—Barrett's esophagus	0.000155	0.00136	CcSEcCtD
Doxorubicin—NOS2—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.000154	0.00325	CbGpPWpGaD
Doxorubicin—Leukopenia—Omeprazole—Barrett's esophagus	0.000154	0.00136	CcSEcCtD
Doxorubicin—Leukopenia—Esomeprazole—Barrett's esophagus	0.000154	0.00136	CcSEcCtD
Doxorubicin—Palpitations—Omeprazole—Barrett's esophagus	0.000152	0.00134	CcSEcCtD
Doxorubicin—Palpitations—Esomeprazole—Barrett's esophagus	0.000152	0.00134	CcSEcCtD
Doxorubicin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000151	0.00317	CbGpPWpGaD
Doxorubicin—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00015	0.00316	CbGpPWpGaD
Doxorubicin—Cough—Esomeprazole—Barrett's esophagus	0.00015	0.00132	CcSEcCtD
Doxorubicin—Cough—Omeprazole—Barrett's esophagus	0.00015	0.00132	CcSEcCtD
Doxorubicin—NOS2—AGE/RAGE pathway—RELA—Barrett's esophagus	0.00015	0.00315	CbGpPWpGaD
Doxorubicin—ABCB1—digestive system—Barrett's esophagus	0.000149	0.00366	CbGeAlD
Doxorubicin—Hypertension—Esomeprazole—Barrett's esophagus	0.000148	0.00131	CcSEcCtD
Doxorubicin—Hypertension—Omeprazole—Barrett's esophagus	0.000148	0.00131	CcSEcCtD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000148	0.00312	CbGpPWpGaD
Doxorubicin—Chest pain—Omeprazole—Barrett's esophagus	0.000146	0.00129	CcSEcCtD
Doxorubicin—Myalgia—Omeprazole—Barrett's esophagus	0.000146	0.00129	CcSEcCtD
Doxorubicin—Arthralgia—Omeprazole—Barrett's esophagus	0.000146	0.00129	CcSEcCtD
Doxorubicin—Arthralgia—Esomeprazole—Barrett's esophagus	0.000146	0.00129	CcSEcCtD
Doxorubicin—Myalgia—Esomeprazole—Barrett's esophagus	0.000146	0.00129	CcSEcCtD
Doxorubicin—Chest pain—Esomeprazole—Barrett's esophagus	0.000146	0.00129	CcSEcCtD
Doxorubicin—Anxiety—Omeprazole—Barrett's esophagus	0.000146	0.00128	CcSEcCtD
Doxorubicin—Anxiety—Esomeprazole—Barrett's esophagus	0.000146	0.00128	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000145	0.00128	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000145	0.00128	CcSEcCtD
Doxorubicin—NOS3—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000145	0.00306	CbGpPWpGaD
Doxorubicin—Discomfort—Omeprazole—Barrett's esophagus	0.000145	0.00127	CcSEcCtD
Doxorubicin—Discomfort—Esomeprazole—Barrett's esophagus	0.000145	0.00127	CcSEcCtD
Doxorubicin—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000144	0.00303	CbGpPWpGaD
Doxorubicin—Dry mouth—Omeprazole—Barrett's esophagus	0.000143	0.00126	CcSEcCtD
Doxorubicin—Dry mouth—Esomeprazole—Barrett's esophagus	0.000143	0.00126	CcSEcCtD
Doxorubicin—Confusional state—Omeprazole—Barrett's esophagus	0.000142	0.00125	CcSEcCtD
Doxorubicin—Confusional state—Esomeprazole—Barrett's esophagus	0.000142	0.00125	CcSEcCtD
Doxorubicin—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00014	0.00124	CcSEcCtD
Doxorubicin—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00014	0.00124	CcSEcCtD
Doxorubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—Barrett's esophagus	0.00014	0.00294	CbGpPWpGaD
Doxorubicin—Infection—Esomeprazole—Barrett's esophagus	0.000139	0.00123	CcSEcCtD
Doxorubicin—Infection—Omeprazole—Barrett's esophagus	0.000139	0.00123	CcSEcCtD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000138	0.00291	CbGpPWpGaD
Doxorubicin—Shock—Esomeprazole—Barrett's esophagus	0.000138	0.00122	CcSEcCtD
Doxorubicin—Shock—Omeprazole—Barrett's esophagus	0.000138	0.00122	CcSEcCtD
Doxorubicin—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000138	0.00121	CcSEcCtD
Doxorubicin—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000138	0.00121	CcSEcCtD
Doxorubicin—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000137	0.00121	CcSEcCtD
Doxorubicin—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000137	0.00121	CcSEcCtD
Doxorubicin—Tachycardia—Esomeprazole—Barrett's esophagus	0.000137	0.00121	CcSEcCtD
Doxorubicin—Tachycardia—Omeprazole—Barrett's esophagus	0.000137	0.00121	CcSEcCtD
Doxorubicin—Skin disorder—Esomeprazole—Barrett's esophagus	0.000136	0.0012	CcSEcCtD
Doxorubicin—Skin disorder—Omeprazole—Barrett's esophagus	0.000136	0.0012	CcSEcCtD
Doxorubicin—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000136	0.00119	CcSEcCtD
Doxorubicin—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000136	0.00119	CcSEcCtD
Doxorubicin—Anorexia—Esomeprazole—Barrett's esophagus	0.000134	0.00118	CcSEcCtD
Doxorubicin—Anorexia—Omeprazole—Barrett's esophagus	0.000134	0.00118	CcSEcCtD
Doxorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000133	0.00279	CbGpPWpGaD
Doxorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000133	0.00279	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—APC—Barrett's esophagus	0.000132	0.00279	CbGpPWpGaD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—Barrett's esophagus	0.000132	0.00277	CbGpPWpGaD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.00013	0.00275	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—HGF—Barrett's esophagus	0.00013	0.00274	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTGES—Barrett's esophagus	0.000129	0.00272	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTGES—Barrett's esophagus	0.000129	0.00272	CbGpPWpGaD
Doxorubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000129	0.00271	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000128	0.00113	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000128	0.00113	CcSEcCtD
Doxorubicin—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000127	0.00268	CbGpPWpGaD
Doxorubicin—Insomnia—Omeprazole—Barrett's esophagus	0.000127	0.00112	CcSEcCtD
Doxorubicin—Insomnia—Esomeprazole—Barrett's esophagus	0.000127	0.00112	CcSEcCtD
Doxorubicin—Paraesthesia—Omeprazole—Barrett's esophagus	0.000126	0.00111	CcSEcCtD
Doxorubicin—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000126	0.00111	CcSEcCtD
Doxorubicin—Dyspnoea—Omeprazole—Barrett's esophagus	0.000125	0.0011	CcSEcCtD
Doxorubicin—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000125	0.0011	CcSEcCtD
Doxorubicin—Somnolence—Omeprazole—Barrett's esophagus	0.000125	0.0011	CcSEcCtD
Doxorubicin—Somnolence—Esomeprazole—Barrett's esophagus	0.000125	0.0011	CcSEcCtD
Doxorubicin—Dyspepsia—Omeprazole—Barrett's esophagus	0.000124	0.00109	CcSEcCtD
Doxorubicin—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000124	0.00109	CcSEcCtD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000123	0.00258	CbGpPWpGaD
Doxorubicin—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000122	0.00107	CcSEcCtD
Doxorubicin—Decreased appetite—Omeprazole—Barrett's esophagus	0.000122	0.00107	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000122	0.00256	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTGES—Barrett's esophagus	0.000121	0.00256	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000121	0.00255	CbGpPWpGaD
Doxorubicin—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000121	0.00107	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000121	0.00107	CcSEcCtD
Doxorubicin—Fatigue—Omeprazole—Barrett's esophagus	0.000121	0.00107	CcSEcCtD
Doxorubicin—Fatigue—Esomeprazole—Barrett's esophagus	0.000121	0.00107	CcSEcCtD
Doxorubicin—Pain—Omeprazole—Barrett's esophagus	0.00012	0.00106	CcSEcCtD
Doxorubicin—Pain—Esomeprazole—Barrett's esophagus	0.00012	0.00106	CcSEcCtD
Doxorubicin—Constipation—Omeprazole—Barrett's esophagus	0.00012	0.00106	CcSEcCtD
Doxorubicin—Constipation—Esomeprazole—Barrett's esophagus	0.00012	0.00106	CcSEcCtD
Doxorubicin—CYP1B1—Biological oxidations—CYP26A1—Barrett's esophagus	0.00012	0.00252	CbGpPWpGaD
Doxorubicin—YWHAG—LKB1 signaling events—TP53—Barrett's esophagus	0.000119	0.00251	CbGpPWpGaD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.000118	0.00249	CbGpPWpGaD
Doxorubicin—CYP1B1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000118	0.00248	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000118	0.00248	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000116	0.00245	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000116	0.00102	CcSEcCtD
Doxorubicin—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000116	0.00102	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000115	0.00101	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000115	0.00101	CcSEcCtD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000113	0.00239	CbGpPWpGaD
Doxorubicin—Urticaria—Omeprazole—Barrett's esophagus	0.000111	0.000982	CcSEcCtD
Doxorubicin—Urticaria—Esomeprazole—Barrett's esophagus	0.000111	0.000982	CcSEcCtD
Doxorubicin—Body temperature increased—Omeprazole—Barrett's esophagus	0.000111	0.000977	CcSEcCtD
Doxorubicin—Abdominal pain—Omeprazole—Barrett's esophagus	0.000111	0.000977	CcSEcCtD
Doxorubicin—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000111	0.000977	CcSEcCtD
Doxorubicin—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000111	0.000977	CcSEcCtD
Doxorubicin—TOP2A—Gastric Cancer Network 2—TP53—Barrett's esophagus	0.000108	0.00228	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN2A—Barrett's esophagus	0.000107	0.00226	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000107	0.00226	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—RELA—Barrett's esophagus	0.000105	0.00221	CbGpPWpGaD
Doxorubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000104	0.0022	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000103	0.00091	CcSEcCtD
Doxorubicin—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000103	0.00091	CcSEcCtD
Doxorubicin—DHCR7—Metabolism—PTGES—Barrett's esophagus	0.000103	0.00217	CbGpPWpGaD
Doxorubicin—XDH—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000102	0.00214	CbGpPWpGaD
Doxorubicin—Asthenia—Esomeprazole—Barrett's esophagus	0.000101	0.000887	CcSEcCtD
Doxorubicin—Asthenia—Omeprazole—Barrett's esophagus	0.000101	0.000887	CcSEcCtD
Doxorubicin—NOS1—Alzheimers Disease—TP53—Barrett's esophagus	9.95e-05	0.00209	CbGpPWpGaD
Doxorubicin—Pruritus—Omeprazole—Barrett's esophagus	9.93e-05	0.000874	CcSEcCtD
Doxorubicin—Pruritus—Esomeprazole—Barrett's esophagus	9.93e-05	0.000874	CcSEcCtD
Doxorubicin—XDH—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	9.88e-05	0.00208	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CYP26A1—Barrett's esophagus	9.78e-05	0.00206	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CYP26A1—Barrett's esophagus	9.78e-05	0.00206	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGES—Barrett's esophagus	9.62e-05	0.00203	CbGpPWpGaD
Doxorubicin—Diarrhoea—Esomeprazole—Barrett's esophagus	9.6e-05	0.000845	CcSEcCtD
Doxorubicin—Diarrhoea—Omeprazole—Barrett's esophagus	9.6e-05	0.000845	CcSEcCtD
Doxorubicin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.6e-05	0.00202	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—APC—Barrett's esophagus	9.47e-05	0.00199	CbGpPWpGaD
Doxorubicin—Dizziness—Esomeprazole—Barrett's esophagus	9.28e-05	0.000817	CcSEcCtD
Doxorubicin—Dizziness—Omeprazole—Barrett's esophagus	9.28e-05	0.000817	CcSEcCtD
Doxorubicin—NDUFS2—Metabolism—CYP26A1—Barrett's esophagus	9.2e-05	0.00194	CbGpPWpGaD
Doxorubicin—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	9.19e-05	0.00194	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	9.15e-05	0.00193	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—PTGS2—Barrett's esophagus	9.15e-05	0.00193	CbGpPWpGaD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—TP53—Barrett's esophagus	9.11e-05	0.00192	CbGpPWpGaD
Doxorubicin—Vomiting—Omeprazole—Barrett's esophagus	8.92e-05	0.000786	CcSEcCtD
Doxorubicin—Vomiting—Esomeprazole—Barrett's esophagus	8.92e-05	0.000786	CcSEcCtD
Doxorubicin—NOS3—Corticotropin-releasing hormone—RELA—Barrett's esophagus	8.92e-05	0.00188	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	8.89e-05	0.00187	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	8.87e-05	0.00187	CbGpPWpGaD
Doxorubicin—Rash—Esomeprazole—Barrett's esophagus	8.85e-05	0.000779	CcSEcCtD
Doxorubicin—Rash—Omeprazole—Barrett's esophagus	8.85e-05	0.000779	CcSEcCtD
Doxorubicin—Dermatitis—Esomeprazole—Barrett's esophagus	8.84e-05	0.000778	CcSEcCtD
Doxorubicin—Dermatitis—Omeprazole—Barrett's esophagus	8.84e-05	0.000778	CcSEcCtD
Doxorubicin—Headache—Esomeprazole—Barrett's esophagus	8.79e-05	0.000774	CcSEcCtD
Doxorubicin—Headache—Omeprazole—Barrett's esophagus	8.79e-05	0.000774	CcSEcCtD
Doxorubicin—ABCC1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.6e-05	0.00181	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	8.56e-05	0.0018	CbGpPWpGaD
Doxorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	8.42e-05	0.00177	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	8.4e-05	0.00177	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.34e-05	0.00176	CbGpPWpGaD
Doxorubicin—Nausea—Omeprazole—Barrett's esophagus	8.34e-05	0.000734	CcSEcCtD
Doxorubicin—Nausea—Esomeprazole—Barrett's esophagus	8.34e-05	0.000734	CcSEcCtD
Doxorubicin—CYP1B1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.32e-05	0.00175	CbGpPWpGaD
Doxorubicin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	8.31e-05	0.00175	CbGpPWpGaD
Doxorubicin—ABCC3—NRF2 pathway—HGF—Barrett's esophagus	8.26e-05	0.00174	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8e-05	0.00168	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	7.98e-05	0.00168	CbGpPWpGaD
Doxorubicin—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.87e-05	0.00166	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CYP26A1—Barrett's esophagus	7.82e-05	0.00165	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—PPARG—Barrett's esophagus	7.59e-05	0.0016	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CYP26A1—Barrett's esophagus	7.29e-05	0.00154	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—TP53—Barrett's esophagus	7.22e-05	0.00152	CbGpPWpGaD
Doxorubicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	7.08e-05	0.00149	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—SLC9A1—Barrett's esophagus	7.05e-05	0.00148	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—SLC9A1—Barrett's esophagus	7.05e-05	0.00148	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	6.93e-05	0.00146	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	6.82e-05	0.00144	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.78e-05	0.00143	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HGF—Barrett's esophagus	6.71e-05	0.00141	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—SLC9A1—Barrett's esophagus	6.63e-05	0.0014	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—HGF—Barrett's esophagus	6.55e-05	0.00138	CbGpPWpGaD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	6.28e-05	0.00132	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.27e-05	0.00132	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.06e-05	0.00128	CbGpPWpGaD
Doxorubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	6e-05	0.00126	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—Barrett's esophagus	5.98e-05	0.00126	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—GAST—Barrett's esophagus	5.83e-05	0.00123	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.78e-05	0.00122	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	5.76e-05	0.00121	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—SLC9A1—Barrett's esophagus	5.64e-05	0.00119	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGES—Barrett's esophagus	5.62e-05	0.00118	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.6e-05	0.00118	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	5.54e-05	0.00117	CbGpPWpGaD
Doxorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	5.52e-05	0.00116	CbGpPWpGaD
Doxorubicin—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	5.47e-05	0.00115	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TP53—Barrett's esophagus	5.44e-05	0.00115	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGES—Barrett's esophagus	5.42e-05	0.00114	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.39e-05	0.00113	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.37e-05	0.00113	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.31e-05	0.00112	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—SLC9A1—Barrett's esophagus	5.26e-05	0.00111	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—PPARG—Barrett's esophagus	5.19e-05	0.00109	CbGpPWpGaD
Doxorubicin—NOS1—Disease—SLC9A1—Barrett's esophagus	5.1e-05	0.00107	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HGF—Barrett's esophagus	5.06e-05	0.00107	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGES—Barrett's esophagus	5.04e-05	0.00106	CbGpPWpGaD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	4.75e-05	0.001	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	4.67e-05	0.000984	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGES—Barrett's esophagus	4.58e-05	0.000964	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.54e-05	0.000957	CbGpPWpGaD
Doxorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	4.36e-05	0.000919	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TP53—Barrett's esophagus	4.28e-05	0.000901	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CYP26A1—Barrett's esophagus	4.26e-05	0.000897	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.25e-05	0.000896	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.24e-05	0.000893	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	4.15e-05	0.000875	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.15e-05	0.000875	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CYP26A1—Barrett's esophagus	4.11e-05	0.000865	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SST—Barrett's esophagus	3.99e-05	0.000841	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HGF—Barrett's esophagus	3.93e-05	0.000828	CbGpPWpGaD
Doxorubicin—NOS2—Disease—SLC9A1—Barrett's esophagus	3.85e-05	0.00081	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CYP26A1—Barrett's esophagus	3.82e-05	0.000804	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGES—Barrett's esophagus	3.71e-05	0.000782	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—CDKN2A—Barrett's esophagus	3.71e-05	0.000782	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	3.62e-05	0.000763	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	3.57e-05	0.000753	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGES—Barrett's esophagus	3.56e-05	0.00075	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—TP53—Barrett's esophagus	3.55e-05	0.000749	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SLC9A1—Barrett's esophagus	3.54e-05	0.000745	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CYP26A1—Barrett's esophagus	3.47e-05	0.000731	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.29e-05	0.000694	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.25e-05	0.000685	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GAST—Barrett's esophagus	3.23e-05	0.00068	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PPARG—Barrett's esophagus	3.22e-05	0.000678	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PPARG—Barrett's esophagus	3.22e-05	0.000678	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	3.15e-05	0.000663	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—SLC9A1—Barrett's esophagus	3.07e-05	0.000646	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.03e-05	0.000639	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PPARG—Barrett's esophagus	3.03e-05	0.000637	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SLC9A1—Barrett's esophagus	2.99e-05	0.000629	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—SLC9A1—Barrett's esophagus	2.96e-05	0.000624	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	2.86e-05	0.000603	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP26A1—Barrett's esophagus	2.82e-05	0.000593	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN2A—Barrett's esophagus	2.82e-05	0.000593	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGES—Barrett's esophagus	2.79e-05	0.000588	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—SLC9A1—Barrett's esophagus	2.75e-05	0.00058	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	2.75e-05	0.00058	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GAST—Barrett's esophagus	2.73e-05	0.000575	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP26A1—Barrett's esophagus	2.7e-05	0.000568	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGES—Barrett's esophagus	2.7e-05	0.000568	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PPARG—Barrett's esophagus	2.57e-05	0.000542	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTGS2—Barrett's esophagus	2.53e-05	0.000533	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTGS2—Barrett's esophagus	2.53e-05	0.000533	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.53e-05	0.000533	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	2.53e-05	0.000532	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SLC9A1—Barrett's esophagus	2.5e-05	0.000527	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGES—Barrett's esophagus	2.46e-05	0.000517	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—Barrett's esophagus	2.43e-05	0.000512	CbGpPWpGaD
Doxorubicin—NOS1—Disease—APC—Barrett's esophagus	2.41e-05	0.000508	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PPARG—Barrett's esophagus	2.4e-05	0.000505	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.39e-05	0.000503	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTGS2—Barrett's esophagus	2.38e-05	0.000501	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—Barrett's esophagus	2.25e-05	0.000474	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SST—Barrett's esophagus	2.21e-05	0.000466	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	2.2e-05	0.000464	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP26A1—Barrett's esophagus	2.11e-05	0.000445	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—APC—Barrett's esophagus	2.11e-05	0.000445	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.08e-05	0.000438	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—Barrett's esophagus	2.07e-05	0.000435	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP26A1—Barrett's esophagus	2.05e-05	0.000431	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC9A1—Barrett's esophagus	2.03e-05	0.000427	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTGS2—Barrett's esophagus	2.02e-05	0.000426	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.99e-05	0.00042	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN2A—Barrett's esophagus	1.97e-05	0.000415	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC9A1—Barrett's esophagus	1.95e-05	0.00041	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—Barrett's esophagus	1.89e-05	0.000398	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SST—Barrett's esophagus	1.87e-05	0.000394	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	1.86e-05	0.000392	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	1.84e-05	0.000388	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—Barrett's esophagus	1.83e-05	0.000386	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SLC9A1—Barrett's esophagus	1.82e-05	0.000383	CbGpPWpGaD
Doxorubicin—NOS2—Disease—APC—Barrett's esophagus	1.82e-05	0.000383	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGES—Barrett's esophagus	1.8e-05	0.000379	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—Barrett's esophagus	1.7e-05	0.000358	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—APC—Barrett's esophagus	1.67e-05	0.000352	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RELA—Barrett's esophagus	1.65e-05	0.000348	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.64e-05	0.000345	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.57e-05	0.00033	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—Barrett's esophagus	1.57e-05	0.00033	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.56e-05	0.000329	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCL8—Barrett's esophagus	1.56e-05	0.000328	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.55e-05	0.000326	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SLC9A1—Barrett's esophagus	1.52e-05	0.000321	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.51e-05	0.000318	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC9A1—Barrett's esophagus	1.47e-05	0.00031	CbGpPWpGaD
Doxorubicin—NOS3—Disease—APC—Barrett's esophagus	1.41e-05	0.000298	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PPARG—Barrett's esophagus	1.4e-05	0.000295	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	1.4e-05	0.000295	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—Barrett's esophagus	1.38e-05	0.000291	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	1.36e-05	0.000287	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PPARG—Barrett's esophagus	1.35e-05	0.000285	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	1.34e-05	0.000282	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGES—Barrett's esophagus	1.33e-05	0.00028	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—Barrett's esophagus	1.32e-05	0.000278	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—Barrett's esophagus	1.27e-05	0.000267	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PPARG—Barrett's esophagus	1.26e-05	0.000265	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGES—Barrett's esophagus	1.25e-05	0.000263	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.23e-05	0.000259	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.19e-05	0.00025	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—APC—Barrett's esophagus	1.17e-05	0.000247	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PPARG—Barrett's esophagus	1.14e-05	0.00024	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—Barrett's esophagus	1.1e-05	0.000232	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—Barrett's esophagus	1.1e-05	0.000231	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—Barrett's esophagus	1.07e-05	0.000226	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—Barrett's esophagus	1.06e-05	0.000224	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	1.01e-05	0.000212	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APC—Barrett's esophagus	9.89e-06	0.000208	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—Barrett's esophagus	9.88e-06	0.000208	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	9.83e-06	0.000207	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—Barrett's esophagus	9.55e-06	0.000201	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	9.48e-06	0.0002	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—Barrett's esophagus	9.26e-06	0.000195	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RELA—Barrett's esophagus	9.15e-06	0.000193	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—Barrett's esophagus	8.98e-06	0.000189	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—Barrett's esophagus	8.88e-06	0.000187	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL8—Barrett's esophagus	8.62e-06	0.000182	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APC—Barrett's esophagus	8.61e-06	0.000181	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	8.34e-06	0.000176	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGES—Barrett's esophagus	8.18e-06	0.000172	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RELA—Barrett's esophagus	7.73e-06	0.000163	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—Barrett's esophagus	7.29e-06	0.000153	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—Barrett's esophagus	7.29e-06	0.000153	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	7.25e-06	0.000153	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—Barrett's esophagus	6.99e-06	0.000147	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—Barrett's esophagus	6.96e-06	0.000147	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	6.83e-06	0.000144	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—Barrett's esophagus	6.73e-06	0.000142	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—Barrett's esophagus	6.54e-06	0.000138	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	6.2e-06	0.000131	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—Barrett's esophagus	6.12e-06	0.000129	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—Barrett's esophagus	5.47e-06	0.000115	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—Barrett's esophagus	5.29e-06	0.000111	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—Barrett's esophagus	5.29e-06	0.000111	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—Barrett's esophagus	4.82e-06	0.000101	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—Barrett's esophagus	4.49e-06	9.45e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—Barrett's esophagus	4.47e-06	9.42e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	4.47e-06	9.41e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	3.53e-06	7.44e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—Barrett's esophagus	3.31e-06	6.97e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—Barrett's esophagus	3.12e-06	6.57e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—Barrett's esophagus	2.6e-06	5.48e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	2.45e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—Barrett's esophagus	2.04e-06	4.3e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.6e-06	3.38e-05	CbGpPWpGaD
